Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
This guide covers the pros and cons of Zero Based Budgeting versus Traditional Budgeting, aiding you in selecting the approach that aligns with discipline and goals.
28,655 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
As mortgage conditions shift in 2026, AI is helping real estate agents: make time, win leads, and coordinate loans mo...
The blockchain-focused ETF is tilting toward AI infrastructure assets, signaling a new growth lane for crypto-linked ...
Newrez is rolling out TitlePass in its wholesale channel, allowing brokers to waive the lender title insurance on cer...
Kraft Heinz pauses its planned breakup after a string of profit slips and a Berkshire Hathaway stake-shift. The move ...
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
Solana is trading near $97 as traders weigh a potential move above $100 this month. Analysts point to ETF demand and ...
Micron's stock jumped more than 600% in a year, sparking a lively debate about a possible stock split. This guide bre...
Mexican President Claudia Sheinbaum escalated claims that the United States is meddling in domestic affairs after a h...
Adobe is expected to announce its next chief executive on Thursday, with the board leaning toward an internal candida...
Growing demand for aging-in-place technology is reshaping funding options for seniors. This report explains how rever...